Qingdao Vland Biotech Co Ltd (603739) — Cash Flow Reinvestment Rate
Qingdao Vland Biotech Co Ltd (603739) has a Cash Flow Reinvestment Rate of 0.31x as of September 2025, reinvesting CN¥7.42 Million (capex CN¥7.42 Million ) from operating cash flow of CN¥24.29 Million. Explore 603739 capital expenditure intensity to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Qingdao Vland Biotech Co Ltd Cash Flow Reinvestment Rate (2014–2024)
Historical reinvestment intensity for Qingdao Vland Biotech Co Ltd across 11 annual periods. Also explore 603739 asset base for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Qingdao Vland Biotech Co Ltd (2014–2024)
Year-by-year capital reinvestment analysis for Qingdao Vland Biotech Co Ltd. For live market cap and broader valuation context, see market value of Qingdao Vland Biotech Co Ltd.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.58x | CN¥112.73 Million | CN¥195.41 Million | CN¥104.72 Million | ▼ -82.7% |
| 2023 | 3.34x | CN¥512.30 Million | CN¥153.59 Million | CN¥215.64 Million | ▼ -21.4% |
| 2022 | 4.24x | CN¥404.22 Million | CN¥95.31 Million | CN¥342.02 Million | ▼ -33.3% |
| 2021 | 6.36x | CN¥569.00 Million | CN¥89.51 Million | CN¥493.58 Million | ▲ +274.2% |
| 2020 | 1.70x | CN¥293.88 Million | CN¥173.00 Million | CN¥211.83 Million | ▼ -63.0% |
| 2019 | 4.59x | CN¥299.62 Million | CN¥65.33 Million | CN¥120.17 Million | ▲ +56.7% |
| 2018 | 2.93x | CN¥251.01 Million | CN¥85.75 Million | CN¥71.56 Million | ▲ +50.2% |
| 2017 | 1.95x | CN¥237.50 Million | CN¥121.90 Million | CN¥58.05 Million | ▲ +46.1% |
| 2016 | 1.33x | CN¥206.00 Million | CN¥154.49 Million | CN¥26.55 Million | ▲ +79.0% |
| 2015 | 0.74x | CN¥55.32 Million | CN¥74.27 Million | CN¥55.32 Million | ▼ -14.4% |
| 2014 | 0.87x | CN¥50.93 Million | CN¥58.55 Million | CN¥50.93 Million | — |